The University of Chicago Header Logo

Connection

Girish Venkataraman to Humans

Back to Details
This is a "connection" page, showing publications Girish Venkataraman has written about Humans.
Girish Venkataraman
Connection Strength
0.715
Humans
  1. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 06 18; 14(1):99.
    View in: PubMed
    Score: 0.031
  2. Peripheral T-cell lymphoma with TFH phenotype and associated indolent T-lymphoblastic proliferation. Blood. 2023 08 03; 142(5):493.
    View in: PubMed
    Score: 0.029
  3. Numerous B cells in a mediastinal mass, but not a B-cell lymphoma. Blood. 2022 08 25; 140(8):932.
    View in: PubMed
    Score: 0.028
  4. GLUT1 Immunohistochemistry Is a Highly Sensitive and Relatively Specific Marker for Erythroid Lineage in Benign and Malignant Hematopoietic Tissues. Am J Clin Pathol. 2022 08 04; 158(2):228-234.
    View in: PubMed
    Score: 0.027
  5. TP53/PLCG2-mutated diffuse large B-cell lymphoma richter transformation (DLBCL-RT) of CLL with unusual CD2 and PD-1 expression. Leuk Lymphoma. 2022 11; 63(11):2735-2738.
    View in: PubMed
    Score: 0.027
  6. B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomas. Hum Pathol. 2022 07; 125:48-58.
    View in: PubMed
    Score: 0.027
  7. Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators. Haematologica. 2022 04 01; 107(4):966-969.
    View in: PubMed
    Score: 0.027
  8. An unusual cause for neoplastic eosinophilia: nothing on morphology. Blood. 2020 11 05; 136(19):2242.
    View in: PubMed
    Score: 0.024
  9. Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities. Mod Pathol. 2020 05; 33(5):834-845.
    View in: PubMed
    Score: 0.023
  10. Challenges in the Diagnosis of Gray Zone Lymphomas. Surg Pathol Clin. 2019 Sep; 12(3):709-718.
    View in: PubMed
    Score: 0.022
  11. The thin line between CML and CMML. Blood. 2017 04 27; 129(17):2456.
    View in: PubMed
    Score: 0.019
  12. Red cell agglutination in infectious mononucleosis. Blood. 2016 Mar 03; 127(9):1212.
    View in: PubMed
    Score: 0.018
  13. Current status of prognostication in classical Hodgkin lymphoma. Br J Haematol. 2014 May; 165(3):287-99.
    View in: PubMed
    Score: 0.015
  14. Chediak-Higashi–like granules within leukemic promyelocytes. Blood. 2013 Nov 07; 122(19):3250.
    View in: PubMed
    Score: 0.015
  15. Chronic myelomonocytic leukemia monocytes uniformly display a population of monocytes with CD11c underexpression. Am J Clin Pathol. 2013 Nov; 140(5):686-92.
    View in: PubMed
    Score: 0.015
  16. Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Am J Clin Pathol. 2013 May; 139(5):651-61.
    View in: PubMed
    Score: 0.014
  17. Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood. 2013 Mar 07; 121(10):1795-804.
    View in: PubMed
    Score: 0.014
  18. Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders. Am J Clin Pathol. 2011 Oct; 136(4):625-30.
    View in: PubMed
    Score: 0.013
  19. CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology. 2011 Apr; 58(5):803-5.
    View in: PubMed
    Score: 0.013
  20. Adult T-cell leukemia/lymphoma with Epstein-Barr virus-positive Hodgkin-like cells. Hum Pathol. 2011 Jul; 42(7):1042-6.
    View in: PubMed
    Score: 0.012
  21. Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol. 2011 Mar; 24(3):355-66.
    View in: PubMed
    Score: 0.012
  22. Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol. 2010 Apr; 34(4):589-94.
    View in: PubMed
    Score: 0.012
  23. Morphometric signature differences in nuclei of Gleason pattern 4 areas in Gleason 7 prostate cancer with differing primary grades on needle biopsy. J Urol. 2009 Jan; 181(1):88-93; discussion 93-4.
    View in: PubMed
    Score: 0.011
  24. Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer. Prostate. 2007 Oct 01; 67(14):1524-36.
    View in: PubMed
    Score: 0.010
  25. Morphometric sum optical density as a surrogate marker for ploidy status in prostate cancer: an analysis in 180 biopsies using logistic regression and binary recursive partitioning. Virchows Arch. 2006 Sep; 449(3):302-7.
    View in: PubMed
    Score: 0.009
  26. Accessible calculation of multirater kappa statistics for pathologists. Virchows Arch. 2006 Aug; 449(2):272.
    View in: PubMed
    Score: 0.009
  27. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment. Leuk Res. 2006 Nov; 30(11):1377-84.
    View in: PubMed
    Score: 0.009
  28. Tissue microarrays: potential in the Indian subcontinent. Indian J Cancer. 2005 Jan-Mar; 42(1):9-14.
    View in: PubMed
    Score: 0.008
  29. Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms. Blood Adv. 2024 Nov 26; 8(22):5796-5805.
    View in: PubMed
    Score: 0.008
  30. Incidental detection of non-melanoma neoplasms in sentinel lymph node biopsy for melanoma staging: A retrospective case series. J Cutan Pathol. 2024 Dec; 51(12):1000-1007.
    View in: PubMed
    Score: 0.008
  31. MGA deletion leads to Richter's transformation by modulating mitochondrial OXPHOS. Sci Transl Med. 2024 Jul 31; 16(758):eadg7915.
    View in: PubMed
    Score: 0.008
  32. Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis. Blood Cancer Discov. 2024 May 01; 5(3):164-179.
    View in: PubMed
    Score: 0.008
  33. T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses. Cancer Immunol Res. 2024 03 04; 12(3):296-307.
    View in: PubMed
    Score: 0.008
  34. Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults. Blood Adv. 2024 01 09; 8(1):164-171.
    View in: PubMed
    Score: 0.008
  35. CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition. J Clin Oncol. 2024 Feb 01; 42(4):467-480.
    View in: PubMed
    Score: 0.008
  36. Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program. Am J Pathol. 2024 01; 194(1):165-178.
    View in: PubMed
    Score: 0.007
  37. Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia. Clin Cancer Res. 2023 08 15; 29(16):3151-3161.
    View in: PubMed
    Score: 0.007
  38. A case of reactive granulomatous dermatitis associated with neonatal lupus erythematosus. J Cutan Pathol. 2023 Sep; 50(9):793-797.
    View in: PubMed
    Score: 0.007
  39. TIGIT is a key inhibitory checkpoint receptor in lymphoma. J Immunother Cancer. 2023 06; 11(6).
    View in: PubMed
    Score: 0.007
  40. Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2023 03 28; 7(6):963-970.
    View in: PubMed
    Score: 0.007
  41. Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer J. 2021 02 18; 11(2):39.
    View in: PubMed
    Score: 0.006
  42. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study. Genes Chromosomes Cancer. 2020 08; 59(8):484-494.
    View in: PubMed
    Score: 0.006
  43. A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab. J Immunother Cancer. 2020 03; 8(1).
    View in: PubMed
    Score: 0.006
  44. Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma. Leukemia. 2020 08; 34(8):2238-2242.
    View in: PubMed
    Score: 0.006
  45. Rosai-Dorfman Disease of the Breast With Variable IgG4+ Plasma Cells: A Diagnostic Mimicker of Other Malignant and Reactive Entities. Am J Surg Pathol. 2019 12; 43(12):1653-1660.
    View in: PubMed
    Score: 0.006
  46. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Blood Adv. 2019 10 08; 3(19):2790-2799.
    View in: PubMed
    Score: 0.006
  47. Bone Marrow Findings in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide. Am J Clin Pathol. 2019 10 07; 152(5):675-685.
    View in: PubMed
    Score: 0.006
  48. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS). Ann Diagn Pathol. 2019 Dec; 43:151404.
    View in: PubMed
    Score: 0.006
  49. PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype. Blood. 2019 05 23; 133(21):2279-2290.
    View in: PubMed
    Score: 0.005
  50. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities. Appl Immunohistochem Mol Morphol. 2019 03; 27(3):180-184.
    View in: PubMed
    Score: 0.005
  51. Correlation of cytopathology with flow cytometry and histopathology for the diagnosis of hematologic malignancies in young adults presenting with cervical lymphadenopathy. Diagn Cytopathol. 2019 Jun; 47(6):579-583.
    View in: PubMed
    Score: 0.005
  52. Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma. Blood Adv. 2018 08 28; 2(16):2039-2051.
    View in: PubMed
    Score: 0.005
  53. Predominance of CD4+ T Cells in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma and Identification of a Subset of Patients With Peripheral B-Cell Lymphopenia. Am J Clin Pathol. 2017 Jun 01; 147(6):596-603.
    View in: PubMed
    Score: 0.005
  54. Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL. Oncotarget. 2016 Oct 18; 7(42):68833-68841.
    View in: PubMed
    Score: 0.005
  55. Cyclin D1 expression in peripheral T-cell lymphomas. Mod Pathol. 2016 11; 29(11):1306-1312.
    View in: PubMed
    Score: 0.005
  56. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Mod Pathol. 2016 10; 29(10):1173-82.
    View in: PubMed
    Score: 0.004
  57. De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. Am J Hematol. 2016 Jun; 91(4):395-9.
    View in: PubMed
    Score: 0.004
  58. Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults. Leuk Lymphoma. 2016; 57(4):866-71.
    View in: PubMed
    Score: 0.004
  59. Knowledge and theme discovery across very large biological data sets using distributed queries: a prototype combining unstructured and structured data. PLoS One. 2013; 8(12):e80503.
    View in: PubMed
    Score: 0.004
  60. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol. 2013 Jun; 37(6):816-26.
    View in: PubMed
    Score: 0.004
  61. Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML). Pathology. 2012 Jan; 44(1):59.
    View in: PubMed
    Score: 0.003
  62. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011 May 05; 117(18):4726-35.
    View in: PubMed
    Score: 0.003
  63. EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010 Mar; 34(3):405-17.
    View in: PubMed
    Score: 0.003
  64. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol. 2009 Jan; 33(1):91-8.
    View in: PubMed
    Score: 0.003
  65. Oncocytic epithelial-myoepithelial carcinoma: an evolving new variant with comparative immunohistochemistry. Pathology. 2008 Jun; 40(4):415-8.
    View in: PubMed
    Score: 0.003
  66. Ewing's sarcoma/primitive neuroectodermal tumour in a possible primary testicular location. Pathology. 2007 Dec; 39(6):599-601.
    View in: PubMed
    Score: 0.002
  67. Validation of World Health Organization/International Society of Urologic Pathology 2004 classification schema for bladder urothelial carcinomas using quantitative nuclear morphometry: identification of predictive features using bootstrap method. Urology. 2007 Nov; 70(5):1028-33.
    View in: PubMed
    Score: 0.002
  68. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol. 2007 Sep; 31(9):1420-9.
    View in: PubMed
    Score: 0.002
  69. Interobserver agreement in the interpretation of chromogenic in situ hybridization for detection of human papillomavirus in gynecologic cytology: an appraisal of 55 cases. Acta Cytol. 2007 May-Jun; 51(3):494-6.
    View in: PubMed
    Score: 0.002
  70. Immunostaining for SYT protein discriminates synovial sarcoma from other soft tissue tumors: analysis of 146 cases. Mod Pathol. 2007 May; 20(5):522-8.
    View in: PubMed
    Score: 0.002
  71. Utility of prostate biopsy morphometric sum optical density for identifying extraprostatic extension on subsequent prostatectomy. Anal Quant Cytol Histol. 2006 Dec; 28(6):343-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.